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Summary
At the University Hospital for Tumors, University Hospital Center Sestre milosrdnice about 700 breast cancers and 
about 150 benign changes of the breast are operated annually. After mammography and ultrasound, basic distinction 
 between benign and malignant is achieved by fi ne needle (FNAC aspiration) under visual control of various radiological 
methods, mainly ultrasound (US).
Importance of early cancer diagnosis and planned treatment action achieve the best outcomes. In order to bridge the 
time gap between diff erent diagnostics and reduce psychological stress, we introduced the concept of one-day clinic into our 
outpatient practice. Service comprises triple diagnostic test when a lesion is suspected along with treatment plan according 
to the diagnosis in 8 hour time frame.
The service has been operating for the past two years and has had positive response from both staff  and patients.
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JEDNODNEVNA DIJAGNOSTIKA
Sažetak
U Klinici za tumore Kliničkog bolničkog centra Sestre milosrdnice, godišnje se operira oko 700 karcinoma dojke i oko 
150 benignih lezija dojke. Nakon mamografi je i ultrazvuka, razlikovanje malignih od benignih tumora se postiže punkcijom 
pod kontrolom različitih radioloških metoda, prvenstveno ultrazvuka.
Važnost ranog otkrivanja raka i planiranje liječenja daju najbolje rezultate. Kako bi se premostili vremenski periodi 
između različitih dijagnostičkih postupaka i reducirao stres koji nastaje iščekivanjem rezultata, uveli smo koncept 
jednodnevne dijagnostike. Usluga se sastoji od trojnog dijagnostičkog testa u slučaju sumnje na tumor i plana liječenja u 
vremenskom okviru od 8 sati.
Jednodnevna dijagnostika djeluje zadnje dvije godine i izazvala je pozitivne reakcije kod pacijenata i kod osoblja.
KLJUČNE RIJEČI:  klinika za bolesti dojke, bolesti dojke, mamografi ja, ultrazvuk dojke, citologija, trodijelni pristup, 
jednodnevna dijagnoza
INTRODUCTION
At the University Hospital for Tumors, Uni-
versity Hospital Center Sestre milosrdnice about 
700 breast cancers and about 150 benign breast le-
sions are operated annually. Radiology performs 
12 000 breast ultrasound and 12 000 mammogra-
phies, as well as about 3000 fi ne needle aspirations 
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(FNA) under visual control of various radiological 
methods, mainly ultrasound (US). Based on the 
experience and organisation of the leading oncol-
ogy centers, such as Institute Gustave Roussy, 
Cambridge University Hospital, Oslo University 
Hospital and Cleveland Clinic, we recognized the 
need for individualized patient approach and rap-
id diagnostics which would solve the benign/ma-
lignant breast lesion dilemma quickly and accu-
rately (1,4).
In past two decades the number of patients 
treated who came from other cities and parts of 
Croatia increased. With their number issues of 
transport to various diagnostics, gett ing the fi nd-
ings and eventually gett ing the specialist counsel-
ling increased the cost of such actions, both in 
their time and eff ectively in resources. Since infra-
structure to implement true multidisciplinary ap-
proach into existing breast cancer diagnosis and 
treatment algorythm already existed at University 
Hospital for Tumors, we merged three protocol 
into one creating a patient oriented one-day diag-
nosis.
Patients who are eligible for one-day diagno-
sis service are the ones who have had suspicious 
MRI or US fi nding previously, or have noticed a 
palpable change in their breast by themselves, and 
have been instructed to investigate it further by 
their general practitioner.
One-day diagnosis of breast lesion implies 
that triple test (clinical examination, mammogra-
phy/ultrasound and FNA/core biopsy) and the fi -
nal specialist consultation is performed with from 
7,30am. to 3pm (2,3). Due to large turnover, about 
3000 aspiration cytologies annually, and a good 
correlation with later pathological report, we rely 
on cytology report as a decisive factor for further 
treatment in one day diagnosis. FNA is a minimal-
ly invasive method which provides analysis im-
mediately after the procedure and at the place 
where it was performed (on-site, one-stop diagno-
sis).The diagnostic procedure and its related risks 
are fi rst discussed with patients, who are informed 
that 1 or 2 supplementary needle passes might be 
needed. An informed consent is acquired. Cyto-
logical report is issued within 30 minutes. In case 
of unclear cytological fi ndings, additional proce-
dures may include core biopsy or additional aspi-
rations providing material for immunocytochem-
istry (ICC) smears.
Depending on the cytology or core biopsy 
based diagnosis and the clinical staging after the 
triple test will be referred to a surgeon, medical 
oncologist, radiation oncologist or multidisci-
plinary team meeting for the plan of their treat-
ment. Currently, this service is available one day a 
week. On that day the entire team of experts is 
dedicated exclusively to one-day diagnosis. The 
team consists minimally of radiologists and a cy-
tologist while surgeons, oncologists and radio-
therapists are available on call.
Patients in process of one-day diagnosis can 
use specially arranged area which is furbished 
with entertainment materials to make the un-
avoidable waiting period as comfortable as possi-
ble. Moreover, psychologist and/or psychiatrist is 
available in order to provide professional att en-
tion to the psychological needs of patients (1,2).
Since the service opened in 2013 we per-
formed 639 fi ne needle aspirations on patients 
with one or more lesions, from which 237 breast 
cancers (37%) were confi rmed. All patients started 
adequate therapeutic protocols in the shortest 
possible time. When correlating the cytology with 
the pathology with only two false positives and 
none false negative diagnosis were found. In the 
case of false positive cytological diagnosis was 
mucinous carcinoma and epithelial atypia while 
patohistological diagnosis was fi broadenoma with 
prominent mucinous component and adenosis. 
Fine needle aspiration cytology (FNAC) gave the 
predictive value of 99,15% with the sensitivity of 
100% and the specifi city of 99.5%.
Fortunately, most patients who come to one 
day diagnosis belong to other 63% and are dis-
charged usually just with a recommendation for a 
preventive check up scheme and a great relief.
CONCLUSION
We believe that the way of managing breast 
cancer diagnostics has, so far, greatly contributed 
to earlier discovery of lesions with the rational 
consumption of resources and equipment, as well 
as to the satisfaction and improved well-being of 
our patients. Although it is diffi  cult to accurately 
encompass and quantify both the positive psycho-
social and the economic impact of this practice, 
the psychological relief one-day diagnostic service 
brings to our patients seems to be priceless.
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